Although benefits of completely retrospective scientific tests evaluating gene expression signatures as prognostic and predictive parameters are promising, to date none of such signatures continues to be verified to be of enough discriminatory power to be used from the scientific location [70] (LoE 2bC, Back +/?).g., PARP inhibitor) like a conseque